Financials DermTech, Inc.

Equities

DMTK

US24984K1051

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2024-05-01 EDT 5-day change 1st Jan Change
0.617 USD -0.47% Intraday chart for DermTech, Inc. +0.49% -64.74%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 148.4 635.7 469.5 53.48 59.93 21.36 -
Enterprise Value (EV) 1 148.4 635.7 469.5 53.48 59.93 21.36 21.36
P/E ratio -4.41 x -15.6 x -5.83 x -0.46 x -0.57 x -0.28 x -0.3 x
Yield - - - - - - -
Capitalization / Revenue 44.1 x 108 x 39.7 x 3.68 x 3.92 x 1.27 x 1.04 x
EV / Revenue 44.1 x 108 x 39.7 x 3.68 x 3.92 x 1.27 x 1.04 x
EV / EBITDA -8.47 x -18.3 x -6.15 x -0.46 x -0.59 x -0.31 x -0.33 x
EV / FCF - -20,829,403 x - - - - -
FCF Yield - -0% - - - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 11,964 19,595 29,717 30,215 34,243 34,623 -
Reference price 2 12.40 32.44 15.80 1.770 1.750 0.6170 0.6170
Announcement Date 20-03-11 21-03-04 22-03-01 23-03-02 24-02-29 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 3.364 5.885 11.84 14.52 15.3 16.83 20.63
EBITDA 1 -17.52 -34.8 -76.4 -116.5 -101.9 -68.55 -63.95
EBIT 1 -17.6 -35.29 -77.4 -118.2 -103.7 -79.13 -74.34
Operating Margin -523.34% -599.64% -653.81% -813.92% -678.21% -470.29% -360.32%
Earnings before Tax (EBT) 1 - -35.25 -78.34 -116.7 -100.9 -77.34 -74.75
Net income 1 -19.69 -35.25 -78.34 -116.7 -100.9 -77.26 -73.24
Net margin -585.29% -598.96% -661.72% -803.71% -659.57% -459.18% -354.99%
EPS 2 -2.810 -2.080 -2.710 -3.880 -3.090 -2.213 -2.053
Free Cash Flow - -30.52 - - - - -
FCF margin - -518.57% - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 20-03-11 21-03-04 22-03-01 23-03-02 24-02-29 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 3.03 3.165 3.718 4.233 3.573 2.994 3.477 3.98 3.915 3.924 3.925 4.165 4.304 4.465 4.602
EBITDA 1 -20.07 -26.02 -29.82 -29.44 -28.84 -28.43 -31.58 -31.66 -19.36 -19.31 -20.4 -18.3 -18.2 -18.2 -17.7
EBIT 1 -20.32 -26.36 -30.19 -29.83 -29.26 -28.88 -32.04 -32.13 -19.81 -19.75 -20.7 -19.43 -19.48 -19.52 -19.23
Operating Margin -670.59% -832.83% -812.02% -704.8% -818.95% -964.56% -921.63% -807.34% -506% -503.36% -527.45% -466.43% -452.55% -437.21% -417.85%
Earnings before Tax (EBT) 1 -20.11 -26.05 -30.11 -29.58 -28.77 -28.22 -31.27 -31.36 -19.16 -19.09 -20.05 -19.04 -19.06 -19.18 -19.13
Net income 1 -20.11 -26.05 -30.11 -29.58 -28.77 -28.22 -31.27 -31.36 -19.16 -19.09 -20.17 -18.96 -19.01 -19.09 -19.13
Net margin -663.76% -823.16% -809.79% -698.8% -805.26% -942.65% -899.34% -788.02% -489.5% -486.52% -513.86% -455.22% -441.7% -427.5% -415.67%
EPS 2 -0.6800 -0.8800 -1.010 -0.9900 -0.9600 -0.9300 -1.020 -0.9900 -0.5700 -0.5400 -0.5833 -0.5433 -0.5400 -0.5400 -0.5350
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 21-11-09 22-03-01 22-05-03 22-08-08 22-11-03 23-03-02 23-05-04 23-08-03 23-11-02 24-02-29 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - -30.5 - - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex - 1.83 2.72 - - - -
Capex / Sales - 31.16% 22.98% - - - -
Announcement Date 20-03-11 21-03-04 22-03-01 23-03-02 24-02-29 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
0.617 USD
Average target price
2.043 USD
Spread / Average Target
+231.17%
Consensus
  1. Stock Market
  2. Equities
  3. DMTK Stock
  4. Financials DermTech, Inc.